A typical drug product development process involves five steps: Discovery and Development, Preclinical Research, Clinical Research, FDA Review, and Post-Market Safety Monitoring.
An overview of the general CMC considerations based on common industry-adopted drug development approaches for various phases of oral solid drug product development of small molecules for the US market is presented in this white paper.
